Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the influence of colloid versus crystalloid volume
resuscitation and of intensive vs conventional insulin therapy on morbidity and mortality of
patients with severe sepsis and septic shock.
Phase:
Phase 3
Details
Lead Sponsor:
German Competence Network Sepsis SepNet - Critical Care Trials Group
Collaborators:
B. Braun Melsungen AG German Federal Ministry of Education and Research HemoCue Gmbh, Großostheim, Germany Novo Nordisk A/S